Cite
HARVARD Citation
Ruiz-Llorente, L. et al. (n.d.). Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Expert opinion on therapeutic targets. pp. 933-947. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ruiz-Llorente, L. et al. (n.d.). Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Expert opinion on therapeutic targets. pp. 933-947. [Online].